Espinosa, Gerard

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 974

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 678

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

Cervera, R., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Kiss, E., Zeher, M. M., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., et al. (2009) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 286

14th International Congress on antiphospholipid antibodies Task Force report on catastrophic antiphospholipid syndrome

Cervera, R., Rodríguez-Pintó, I., Colafrancesco, S., Conti, F., Valesini, G., Rosário, C., Agmon-Levin, N., Shoenfeld, Y., Ferrão, C., Faria, R., et al. (2014) · Autoimmunity Reviews

Systemic Lupus Erythematosus ResearchVasculitis and related conditions

Cited by 213

Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome

Muñoz-Rodríguez, F. J., Font, J., Cervera, R., Reverter, J. C., Tàssies, D., Espinosa, G., López-Soto, A., Carmona, F., Balasch, J., Ordinas, A., et al. (1999) · Seminars in Arthritis and Rheumatism

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 114

Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative

Coloma Bazán, E., Donate López, C., Moreno Lozano, P., Cervera, R., & Espinosa, G. (2013) · Immunologic Research

Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis Mechanisms

Cited by 57

International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies

Bentow, C., Lakos, G., Martis, P., Wahl, E., Garcia, M., Viñas, O., Espinosa, G., Cervera, R., Sjöwall, C., Carmona-Fernandes, D., et al. (2016) · Lupus

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 37